Considering the emersion of metabolic diseases and the multifunctionality of ACE2, as well as its emerging role in the onset and severity of COVID-19, our aim was to investigate the effect of HFD during the lifespan in ACE2-deficient mice, especially regarding systemic metabolism of lipids and glucose. This evidence concerns the gene ACE2 and metabolic disease.